Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：34

作者：

Bellmunt, J. ^{[1
]}

Orsola, A. ^{[2
]}

Wiegel, T. ^{[3
]}

Guix, M. ^{[1
]}

De Santis, M. ^{[4
]}

Kataja, V. ^{[5
,6
]}

机构：

[1] Univ Hosp Mar IMIM, Dept Med Oncol, Barcelona, Spain

[2] Vall Hebron Univ Hosp, Dept Urol, Barcelona, Spain

[3] Univ Hosp Ulm, Dept Radio Oncol, Ulm, Germany

[4] Zentrum Onkol & Hamatol Kaiser Franz Josef Spital, Vienna, Austria

[5] Vaasa Cent Hosp, Dept Oncol, Vaasa, Finland

[6] Kuopio Univ Hosp, SF-70210 Kuopio, Finland

[7] ESMO Head Off, CH-6962 Viganello Lugano, Switzerland

来源：

ANNALS OF ONCOLOGY | 2011年 / 22卷

关键词：

TRANSITIONAL-CELL CARCINOMA; ADVANCED UROTHELIAL CARCINOMA; SELECTIVE ORGAN PRESERVATION; DOXORUBICIN PLUS GEMCITABINE; COLONY-STIMULATING FACTOR; LONG-TERM-SURVIVAL; PHASE-III TRIAL; RANDOMIZED-TRIAL; G-CSF; CISPLATIN;

D O I：

10.1093/annonc/mdr376

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：vi45 / vi49

页数：5

共 31 条

[1]

[Anonymous], COCHRANE DATABASE SY

[2]

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder [J].

Babjuk, Marko ;

Oosterlinck, Willem ;

Sylvester, Richard ;

Kaasinen, Eero ;

Boehle, Andreas ;

Palou-Redorta, Juan .

EUROPEAN UROLOGY, 2008, 54 (02) :303-314

[3]

Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy [J].

Bajorin, DF ;

Dodd, PM ;

Mazumdar, M ;

Fazzari, M ;

McCaffrey, JA ;

Scher, HI ;

Herr, H ;

Higgins, G ;

Boyle, MG .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3173-3181

[4]

Docetaxel and cisplatin with granulocyte colony-stimulating factor (G-CSF) versus MVAC with G-CSF in advanced urothelial carcinoma: A multicenter, randomized, phase III study from the Hellenic Cooperative Oncology Group [J].

Bamias, A ;

Aravantinos, G ;

Deliveliotis, C ;

Bafaloukos, D ;

Kalofonos, C ;

Xiros, N ;

Zervas, A ;

Mitropoulos, D ;

Samantas, E ;

Pectasides, D ;

Papakostas, P ;

Gika, D ;

Kourousis, C ;

Koutras, A ;

Papadimitriou, C ;

Bamias, C ;

Kosmidis, P ;

Dimopoulos, MA .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :220-228

[5]

Bellmunt J, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.07.0888

[6]

BELLMUNT J, 2008, ASCO GEN CANC S

[7]

Prognostic Factors in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract Experiencing Treatment Failure With Platinum-Containing Regimens [J].

Bellmunt, Joaquim ;

Choueiri, Toni K. ;

Fougeray, Ronan ;

Schutz, Fabio A. B. ;

Salhi, Yacine ;

Winquist, Eric ;

Culine, Stephane ;

von der Maase, Hans ;

Vaughn, David J. ;

Rosenberg, Jonathan E. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (11) :1850-1855

[8]

Phase III Trial of Vinflunine Plus Best Supportive Care Compared With Best Supportive Care Alone After a Platinum-Containing Regimen in Patients With Advanced Transitional Cell Carcinoma of the Urothelial Tract [J].

Bellmunt, Joaquim ;

Theodore, Christine ;

Demkov, Tomasz ;

Komyakov, Boris ;

Sengelov, Lisa ;

Daugaard, Gedske ;

Caty, Armelle ;

Carles, Joan ;

Jagiello-Gruszfeld, Agnieszka ;

Karyakin, Oleg ;

Delgado, Francois-Michel ;

Hurteloup, Patrick ;

Morsli, Nassim ;

Salhi, Yacine ;

Culine, Stephane ;

von der Maase, Hans .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (27) :4454-4461

[9]

Adjuvant chemotherapy in invasive bladder cancer: A systematic review and meta-analysis of individual patient data [J].

Bono, AV ;

Goebell, PJ ;

Groshen, S ;

Lehmann, J ;

Studer, U ;

Torti, FM ;

Abol-Enein, H ;

Bassi, P ;

Boyer, M ;

Coppin, CML ;

Cortesi, E ;

Hall, RR ;

Horwich, A ;

Malmström, PU ;

Martínez-Piñeiro, JA ;

Sengelov, L ;

Sherif, A ;

Wallace, DMA ;

Clarke, NW ;

Roberts, JT ;

Sylvester, R ;

Parmar, MKB ;

Stewart, LA ;

Tierney, JF ;

Vale, CL .

EUROPEAN UROLOGY, 2005, 48 (02) :189-201

[10]

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation [J].

Coppin, CML ;

Gospodarowicz, MK ;

James, K ;

Tannock, IF ;

Zee, B ;

Carson, J ;

Pater, J ;

Sullivan, LD .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) :2901-2907

← 1 2 3 4 →